128 results
Page 4 of 7
6-K
EX-99.1
3u1fiyl fs
21 Apr 15
Teva Proposes to Acquire Mylan for $82.00 Per Share In Cash and Stock
12:00am
425
zlhv3uehzg bsu3h
21 Apr 15
Business combination disclosure
12:00am
6-K
EX-99.1
c9z fe8p4f
6 Feb 14
Teva Reports Fourth Quarter and Full Year 2013 Results
12:00am
6-K
EX-99.1
0myh028mdcy9w1bgplz
29 Jan 14
Teva Announces U.S. FDA Approval of Three-Times-a-Week COPAXONE® (glatiramer acetate injection) 40mg/mL
12:00am
6-K
EX-99.1
ur0d0dgrq zbb9
24 Jan 14
Live Filing
12:00am
6-K
EX-99.1
uo12r9x1v
13 Jan 14
Live Filing
12:00am
6-K
EX-99.1
g0jx 7yjq09
9 Jan 14
Teva Names Erez Vigodman as President and CEO
12:00am
6-K
EX-99.1
eo95hsm
3 Jan 14
Live Filing
12:00am
6-K
EX-99.1
dpu206th1u
17 Dec 13
Teva Settles Viagra® Patent Litigation with Pfizer
12:00am
6-K
EX-99.1
mg0 7elb01o8401
10 Dec 13
Live Filing
12:00am
6-K
EX-99.1
hthj ae2g5o1b8i3v
10 Dec 13
Teva Provides 2014 Non-GAAP Financial Outlook
12:00am
6-K
EX-99.1
d2pxod
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
g8w1mq5iaigxurp0fxz
4 Dec 13
Live Filing
12:00am
6-K
EX-99.1
2swaucs6
4 Dec 13
Teva and Takeda Announce Development and Distribution Agreement for Glatiramer Acetate for Multiple Sclerosis Treatment in Japan
12:00am
6-K
EX-99.1
xoscsqwib289 ks
27 Nov 13
Teva Announces Additional Regulatory Exclusivity for Treanda® (Bendamustine Hci) for Injection
12:00am
6-K
EX-99.1
htcu14g
25 Nov 13
Teva and Mylan Settle Copaxone® Patent Litigation In France, the Uk and the Netherlands
12:00am
6-K
EX-99.1
ikkqthietakcj
25 Nov 13
Live Filing
12:00am